Supplementary Table 5 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Patrick J. Halvey,Xiaojing Wang,Jing Wang,Ajaz A. Bhat,Punita Dhawan,Ming Li,Bing Zhang,Daniel C. Liebler,Robbert J.C. Slebos

DOI: https://doi.org/10.1158/0008-5472.22402449.v1

2023-01-01

Abstract:PDF file - 945K, Customized search spectral table.

What problem does this paper attempt to address?

Supplementary Table 5 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Patrick J. Halvey,Xiaojing Wang,Jing Wang,Ajaz A. Bhat,Punita Dhawan,Ming Li,Bing Zhang,Daniel C. Liebler,Robbert J.C. Slebos

DOI: https://doi.org/10.1158/0008-5472.22402449

2023-01-01

Abstract:PDF file - 945K, Customized search spectral table.
Supplementary Table 3 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Patrick J. Halvey,Xiaojing Wang,Jing Wang,Ajaz A. Bhat,Punita Dhawan,Ming Li,Bing Zhang,Daniel C. Liebler,Robbert J.C. Slebos

DOI: https://doi.org/10.1158/0008-5472.22402452.v1

2023-01-01

Abstract:PDF file - 857K, Standard search spectral table.
Supplementary Table 8 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Patrick J. Halvey,Xiaojing Wang,Jing Wang,Ajaz A. Bhat,Punita Dhawan,Ming Li,Bing Zhang,Daniel C. Liebler,Robbert J.C. Slebos

DOI: https://doi.org/10.1158/0008-5472.22402440.v1

2023-01-01

Abstract:PDF file - 1496K, RKO versus other cell lines.
Supplementary Table 7 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Patrick J. Halvey,Xiaojing Wang,Jing Wang,Ajaz A. Bhat,Punita Dhawan,Ming Li,Bing Zhang,Daniel C. Liebler,Robbert J.C. Slebos

DOI: https://doi.org/10.1158/0008-5472.22402446

2023-01-01

Abstract:PDF file - 1190K, MMR status comparison.
Supplementary Tables 1, 2, 4, 6, 9 - 12 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Patrick J. Halvey,Xiaojing Wang,Jing Wang,Ajaz A. Bhat,Punita Dhawan,Ming Li,Bing Zhang,Daniel C. Liebler,Robbert J.C. Slebos

DOI: https://doi.org/10.1158/0008-5472.22402437.v1

2023-01-01

Abstract:PDF file - 121K, Table S1. Genetic features of cell lines. Table S2. Summary of standard search results. Table S4. Summary of customized search results. Table S6. SelTarBase gene list. Table S9. Parameters for MRM analyses. Table S10. Detailed co-expression module results. Table S11. Observed variant peptides Table S12. Mapping of co-expression cluster results.
Supplementary Figures 1 - 2 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Patrick J. Halvey,Xiaojing Wang,Jing Wang,Ajaz A. Bhat,Punita Dhawan,Ming Li,Bing Zhang,Daniel C. Liebler,Robbert J.C. Slebos

DOI: https://doi.org/10.1158/0008-5472.22402455.v1

2023-01-01

Abstract:PDF file - 909K, Figure 1A. Spectra obtained from the customized dataset (Observed) and from a synthetic GPATCH4 peptide (Synthetic ) Figure 1B. Spectra obtained from the customized dataset (Observed) and from a synthetic CCT8 peptide (Synthetic ) Figure 1C. Spectra obtained from the customized dataset (Observed) and from a synthetic ANXA11 peptide (Synthetic ) Figure 1D. Spectra obtained from the customized dataset (Observed) and from a synthetic SRSF9 peptide (Synthetic ) Figure 1E. Spectra obtained from the customized dataset (Observed) and from a synthetic CEACAM1 peptide (Synthetic ) Figure 1F. Spectra obtained from the customized dataset (Observed) and from a synthetic EBP41L1 peptide (Synthetic ) Figure S2. Comparison of spectral count results with MRM results for selected proteins. Panel A, HSP90AB1; Panel B, HSP90AA1; Panel C, BAG3; Panel D, TNOP1; Panel E, FECH; Panel F, TTC19; Panel G, CAND1; Panel H, CARM1; Panel I, NARS ; Panel J, PAICS; Panel K, PFAS; Panel L, EEF2; Panel M, CPD; Panel N, DSTN; Panel O, ESRP1; Panel P, ERAP1, Panel Q, KRT8; Panel R, KRT18; Panel S, KRT19; and Panel T, CDH1.
Supplementary Tables 1-5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934664.v1

2024-01-01

Abstract:Supplementary tables of the revised manuscript.
Supplementary Table S1 from Germline Mutations of Holliday Junction Resolvase Genes in Multiple Primary Malignancies Involving Lung Cancer Lead to PARP Inhibitor Sensitization

Haoran Wang,Yuping Chen,Xinshu Wang,Binhao Huang,Juntao Xie,Hui Yin,Jie Yang,Jinhuan Wu,Jian Yuan,Jie Zhang

DOI: https://doi.org/10.1158/1078-0432.25603569.v1

2024-01-01

Abstract:Supplementary Table S1: The gene list for pathway enrichment analysis.
Supplementary Table S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Wenju Chang,Zhou Zhang,Baoqing Jia,Kefeng Ding,Zhizhong Pan,Guoqiang Su,Wei Zhang,Tianyu Liu,Yunshi Zhong,Guodong He,Li Ren,Ye Wei,Dongdong Li,Xiaolong Cui,Jun Yang,Yixiang Shi,Marc Bissonnette,Chuan He,Wei Zhang,Jia Fan,Jianmin Xu

DOI: https://doi.org/10.1158/1078-0432.26422958.v1

2024-01-01

Abstract:Differetially modified gene bodies between CRC/AA and controls.
Supplementary Table 1 from Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colorectal Cancer

Jianxia Li,Huabin Hu,Qi Ge,Fan Bai,Xianrui Wu,Haoxian Ke,Jianwei Zhang,Yuqian Xie,Zehua Wu,Yang-Xin Fu,Hongbo Zheng,Longlong Gong,Zhi Xie,Yanhong Deng

DOI: https://doi.org/10.1158/1078-0432.25011269.v1

2024-01-01

Abstract:Clinical characterization of the cohort and allocation for testing
Concurrent Genetic Alterations in DNA Polymerase Proofreading and Mismatch Repair in Human Colorectal Cancer

Rintaro Yoshida,Kaname Miyashita,Mayuko Inoue,Akiyoshi Shimamoto,Zhao Yan,Akinori Egashira,Eiji Oki,Yoshishiro Kakeji,Shinya Oda,Yoshihiko Maehara

DOI: https://doi.org/10.1038/ejhg.2010.216

2010-01-01

European Journal of Human Genetics

Abstract:Genomic sequences encoding the 3′ exonuclease (proofreading) domains of both replicative DNA polymerases, pol delta and pol epsilon, were explored simultaneously in human colorectal carcinomas including six established cell lines. Three unequivocal sequence alterations, including one previously reported, were found, and all these were considered as dysfunctional mutations in light of the local amino-acid sequences. In particular, the F367S mutation found in the POLE gene encoding the pol epsilon catalytic subunit, which includes the proofreading domain, is the first found in human diseases. Surprisingly, the tumours carrying these proofreading domain mutations were all defective in DNA mismatch repair (MMR). In addition to the two cell lines with acknowledged MMR gene mutations, the third tumour was also demonstrated to harbour a distinct mutation in MLH1, and indeed exhibited a microsatellite-unstable phenotype. These findings suggest that, in concert with MMR deficiency, defective polymerase proofreading may also contribute to the mutator phenotype observed in human colorectal cancer. Our observations may suggest previously unrecognised complexities in the molecular abnormalities underlying the mutator phenotype in human neoplasms.
Supp. Table S2 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

Catherine S. Grasso,Marios Giannakis,Daniel K. Wells,Tsuyoshi Hamada,Xinmeng Jasmine Mu,Michael Quist,Jonathan A. Nowak,Reiko Nishihara,Zhi Rong Qian,Kentaro Inamura,Teppei Morikawa,Katsuhiko Nosho,Gabriel Abril-Rodriguez,Charles Connolly,Helena Escuin-Ordinas,Milan S. Geybels,William M. Grady,Li Hsu,Siwen Hu-Lieskovan,Jeroen R. Huyghe,Yeon Joo Kim,Paige Krystofinski,Mark D.M. Leiserson,Dennis J. Montoya,Brian B. Nadel,Matteo Pellegrini,Colin C. Pritchard,Cristina Puig-Saus,Elleanor H. Quist,Ben J. Raphael,Stephen J. Salipante,Daniel Sanghoon Shin,Eve Shinbrot,Brian Shirts,Sachet Shukla,Janet L. Stanford,Wei Sun,Jennifer Tsoi,Alexander Upfill-Brown,David A. Wheeler,Catherine J. Wu,Ming Yu,Syed H. Zaidi,Jesse M. Zaretsky,Stacey B. Gabriel,Eric S. Lander,Levi A. Garraway,Thomas J. Hudson,Charles S. Fuchs,Antoni Ribas,Shuji Ogino,Ulrike Peters

DOI: https://doi.org/10.1158/2159-8290.22532711

2023-01-01

Abstract:Supplementary Table S2: Somatic mutations
Extensive Characterization of Genetic Alterations in a Series of Human Colorectal Cancer Cell Lines.

Jacqueline Gayet,Xiao-Ping Zhou,Alex Duval,Sandra Rolland,Jean-Marc Hoang,Paul Cottu,Richard Hamelin

DOI: https://doi.org/10.1038/sj.onc.1204611

IF: 8.756

2001-01-01

Oncogene

Abstract:A number of genetic alterations have been described in colorectal cancers. They include allelic losses on specific chromosomal arms, mutations of oncogenes, tumor suppressor genes and mismatch repair genes, microsatellite instability in coding repeat sequences of target genes and methylation defects in gene promoters. Since these alterations have been reported by different groups on different tumors and cell lines, the complete repertoire of genetic alterations for any given tumor sample remains unknown. In the present study, we analysed a series of 22 colorectal cancer cell lines for 31 different genetic alterations. We found significant correlations between mutational profiles in these colorectal cell lines associated with differences in mismatch repair status. This panel of colon cancer cell lines is representative of the genetic heterogeneity occurring in sporadic colorectal carcinoma. Our results may prove to be very useful for understanding the different biological pathways involved in the development of colon cancer, and for groups studying cellular biology and pharmacology on the same cell lines.
Supplementary Table 1 from Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis

Xiaojun Zhao,Barbara A. Weir,Thomas LaFramboise,Ming Lin,Rameen Beroukhim,Levi Garraway,Javad Beheshti,Jeffrey C. Lee,Katsuhiko Naoki,William G. Richards,David Sugarbaker,Fei Chen,Mark A. Rubin,Pasi A. Jänne,Luc Girard,John Minna,David Christiani,Cheng Li,William R. Sellers,Matthew Meyerson

DOI: https://doi.org/10.1158/0008-5472.22363815.v1

2023-01-01

Abstract:Supplementary Table 1 from Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis
Supplementary Table 1 from An Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens as Potential Immunologic and Clinical Targets in Cancer

Qing-Wen Xu,Wei Zhao,Yue Wang,Maureen A. Sartor,Dong-Mei Han,Jixin Deng,Rakesh Ponnala,Jiang-Ying Yang,Qing-Yun Zhang,Guo-Qing Liao,Yi-Mei Qu,Lu Li,Fang-Fang Liu,Hong-Mei Zhao,Yan-Hui Yin,Wei-Feng Chen,Yu Zhang,Xiao-Song Wang

DOI: https://doi.org/10.1158/0008-5472.22394709

2023-01-01

Abstract:PDF file - 66K, Detailed information for the adult somatic tissues and cancer tissues from the five Affymetrix U133 plus2 gene expression datasets compiled for HEPA analysis
Supplementary Data from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Jintao Guo,Ying Zhou,Chaoqun Xu,Qinwei Chen,Zsófia Sztupinszki,Judit Börcsök,Canqiang Xu,Feng Ye,Weiwei Tang,Jiapeng Kang,Lu Yang,Jiaxin Zhong,Taoling Zhong,Tianhui Hu,Rongshan Yu,Zoltan Szallasi,Xianming Deng,Qiyuan Li

DOI: https://doi.org/10.1158/0008-5472.22361539.v1

2023-01-01

Abstract:Supplementary Methods, Figures S1-S8, Table S1-S4
Abstract 3854: Revealing mismatch repair deficiency in Egyptian colorectal cancer patients using next generation sequencing a predictive biomarker for immunotherapy efficacy

Amira Salah El-Din Youssef,Mohamed Ragab,Heba Aly Ateya,Mostafa Elberry,Nasra Fathy,Asmaa Elleithy,Abdel Rahman Zekri,Ola Sayed Ahmed,Auhood Nassar

DOI: https://doi.org/10.1158/1538-7445.am2024-3854

IF: 11.2

2024-03-22

Cancer Research

Abstract:Abstract Background: The mismatch repair (MMR) deficiency is a potential predictive biomarker for immunotherapy efficacy, particularly in colorectal cancer (CRC), where alterations in various DNA polymerases and MMR genes are prevalent. The accumulation of these genetic aberrations may cause a subsequent neoantigen formation. study aimed to identify the mutational profile of DNA polymerases and MMR genes in Egyptian CRC patients', providing insights into colorectal carcinogenesis and potential implications for immunotherapy. Material and Methods: Thirty-nine blood samples from Egyptian patients with CRC and twenty-four blood samples from healthy controls were collected. The libraries were prepared by Qiaseq UMI-based targeted panel and sequenced via an Ion proton sequencer. The detected genetic variants with an average coverage of 500x were annotated against Cosmic, dbSNP, and ClinVar databases using Ingenuity Variant analysis (IVA). Results: Our results revealed that the POLD1andPOLE genes (DNA polymerases) in the CRC patients, when compared with healthy controls, harbored 10 and 13 pathogenic variants (PVs), respectively. These PVs cause a loss of their functionality. The most frequently detected PVs and likely to be novel in the POLD1gene werec.44delC(31%)andc.3008delG(31%), while c.3510delA(18%)andc.2793delT(15%) were detected in the POLE gene. As per MMR genes, our study showed that the MLH1, MLH3, MSH2, MSH3, MSH6, PMS1,and PMS2 harbored 8, 13, 23, 19, 22, 23, and 7 PVs, respectively. The highly frequent PV in the MLH1wasc.469delT (26%), while the novel most frequently detected PV in the MLH3 wasc.1467delA (23%). Moreover, the PVs found highly frequent are c.2647delA (36%) in MSH2,c.1148delA (41%)in the MSH3, and c.2079delA (44%) in the MSH6. RegardingPMS1/2, the most frequently detected PV and likely to be novel was c.1647delA (44%) in PMS1, while c.869delT (13%) was the most prevalent PV in PMS2. Conclusion: Our results revealed the MMR mechanism deficiency in Egyptian CRC patients offering crucial insights into colorectal carcinogenesis and neoantigen formation. These insights are pivotal for developing ethnic-based personalized immunotherapy strategies in Egyptian CRC patients, shedding light on their role in CRC. Interestingly, we have identified novel variants in the DNA repair enzymes. However, further investigations and validations are required to corroborate these findings and explore their clinical significance in the personalized medicine. Citation Format: Amira Salah El-Din Youssef, Mohamed Ragab, Heba Aly Ateya, Mostafa Elberry, Nasra Fathy, Asmaa Elleithy, Abdel Rahman Zekri, Ola Sayed Ahmed, Auhood Nassar. Revealing mismatch repair deficiency in Egyptian colorectal cancer patients using next generation sequencing a predictive biomarker for immunotherapy efficacy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3854.

oncology
Supplementary Table 7 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Genee Y. Lee,Peter M. Haverty,Li Li,Noelyn M. Kljavin,Richard Bourgon,James Lee,Howard Stern,Zora Modrusan,Somasekar Seshagiri,Zemin Zhang,David Davis,David Stokoe,Jeffrey Settleman,Frederic J. de Sauvage,Richard M. Neve

DOI: https://doi.org/10.1158/0008-5472.22399124

2023-01-01

Abstract:XLSX file - 37K, Supplementary materials and methods (cell lines, STR profiles, primers, antibodies, molecular reagents).
Supplementary Table 2 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different P53 Mutants

Dhruv Chachad,Lalit R. Patel,Carlos Vera Recio,Rasoul Pourebrahim,Elizabeth M. Whitley,Wenyi Wang,Xiaoping Su,An Xu,Dung-Fang Lee,Guillermina Lozano

DOI: https://doi.org/10.1158/0008-5472.23684077

2023-01-01

Abstract:List of mice belonging to different cohorts
The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer

Hiroyuki Arai,Andrew Elliott,Joanne Xiu,Jingyuan Wang,Francesca Battaglin,Natsuko Kawanishi,Shivani Soni,Wu Zhang,Joshua Millstein,Davendra Sohal,Richard M. Goldberg,Michael J. Hall,Aaron J. Scott,Moh'd Khushman,Jimmy J. Hwang,Emil Lou,Benjamin A. Weinberg,John L. Marshall,Albert C. Lockhart,Phillip Stafford,Jian Zhang,Roberto Moretto,Chiara Cremolini,W. Michael Korn,Heinz-Josef Lenz

DOI: https://doi.org/10.1158/1078-0432.ccr-20-3635

IF: 13.801

2021-03-25

Clinical Cancer Research

Abstract:Abstract Purpose: Defective DNA damage response (DDR) is a hallmark of cancer leading to genomic instability and is associated with chemosensitivity. Although the mismatch repair system has been extensively studied, the clinical implications of other mechanisms associated with DDR alterations in patients with colorectal cancer remain unclear. This study aimed to understand DDR pathways alterations and their association with common clinical features in patients with colorectal cancer. Experimental Design: Next-generation sequencing and whole-transcriptome sequencing were conducted using formalin-fixed paraffin-embedded samples submitted to a commercial Clinical Laboratory Improvement Amendments–certified laboratory. Samples with pathogenic or presumed pathogenic mutations in 29 specific DDR-related genes were considered as DDR-mutant (DDR-MT) and the remaining samples as DDR-wild type (DDR-WT). Results: Of 9,321 patients with colorectal cancer, 1,290 (13.8%) were DDR-MT. The frequency of DDR-MT was significantly higher in microsatellite instability-high (MSI-H) cases than in microsatellite stable cases (76.4% vs. 9.5%). The DDR-MT genotype was higher in the right-sided, RAS-wild, BRAF-mutant, and CMS1 subgroups. However, these associations were primarily confounded by the distribution of MSI status. Compared with the DDR-WT tumors, the DDR-MT tumors had a higher mutational burden and gene expression levels in the immune-related pathway, which were independent of MSI status. Conclusions: We characterized a distinct subgroup of patients with colorectal cancer with tumors harboring mutations in the DDR-related genes. These patients more commonly had MSI-H tumors and exhibited an activated immune signature regardless of their tumor's MSI status. These findings warrant further investigations to develop personalized treatment strategies in this significant subgroup of patients with colorectal cancer.

oncology

Supplementary Table 5 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Supplementary Table 5 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Supplementary Table 3 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Supplementary Table 8 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Supplementary Table 7 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Supplementary Tables 1, 2, 4, 6, 9 - 12 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Supplementary Figures 1 - 2 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Supplementary Tables 1-5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Table S1 from Germline Mutations of Holliday Junction Resolvase Genes in Multiple Primary Malignancies Involving Lung Cancer Lead to PARP Inhibitor Sensitization

Supplementary Table S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Supplementary Table 1 from Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colorectal Cancer

Concurrent Genetic Alterations in DNA Polymerase Proofreading and Mismatch Repair in Human Colorectal Cancer

Supp. Table S2 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

Extensive Characterization of Genetic Alterations in a Series of Human Colorectal Cancer Cell Lines.

Supplementary Table 1 from Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis

Supplementary Table 1 from An Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens as Potential Immunologic and Clinical Targets in Cancer

Supplementary Data from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Abstract 3854: Revealing mismatch repair deficiency in Egyptian colorectal cancer patients using next generation sequencing a predictive biomarker for immunotherapy efficacy

Supplementary Table 7 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Table 2 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different P53 Mutants

The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer